Adaptimmune Therapeutics Plc ADR (ADAPY)

$0.05 0.00 (-1.82%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 45,989,301
Avg Vol 115,232,406
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 15%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Adaptimmune Therapeutics plc, a commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops TECELRA (famitresgene autoleucel or afami-cel), a genetically modified autologous T-cell immunotherapy for the treatment of adults with unresectable or metastatic synovial sarcoma; Lete-cel for the treatment of synovial sarcoma and myxoid liposarcoma; and ADP-5701, which is in Phase 1 clinical trial for the...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 12 3543 0000
Address:
60 Jubilee Avenue, Milton Park, Abingdon, United Kingdom
meatme
meatme Mar. 16 at 8:20 AM
$ADAPY Godoy Almeida said UIHC’s second patient to receive Tecelra therapy started high-dose chemotherapy on March 3, a process that will last for four days, followed by one day of rest and cell infusion the day after rest. https://dailyiowan.com/2026/03/10/rare-cancer-therapy-arrives-at-uihc-iowas-only-medical-center-offering-it/
0 · Reply
Swamp_Yankee
Swamp_Yankee Mar. 15 at 11:02 PM
$ADAPY Piper stole his mother's plastic surgeon's ticket!
0 · Reply
Damage111
Damage111 Mar. 15 at 10:16 PM
$ADAPY I wonder what tomorrow will bring
1 · Reply
BK217
BK217 Mar. 15 at 3:40 PM
$ADAPY HOLD THE LINE!!!
0 · Reply
BK217
BK217 Mar. 15 at 3:38 PM
$ADAPY “think” is doing a lot of heavy lifting here
0 · Reply
duepillagence
duepillagence Mar. 15 at 2:04 PM
$ADAPY $1.50-$2.15 😎
1 · Reply
duepillagence
duepillagence Mar. 15 at 1:06 PM
$ADAPY Question and answer; Can TRUc and iPSCs tech be combined for superior enhancement?:
0 · Reply
meatme
meatme Mar. 15 at 12:47 PM
$ADAPY Key filing to watch: UK Statutory Annual Accounts FY2025 Source: Claude.ai As a UK-incorporated PLC, Adaptimmune remains legally required to file statutory accounts under the Companies Act 2006 — regardless of its SEC deregistration. Deadline: June 30, 2026 (6 months after FY end) This filing will reveal: - Final cash position post US WorldMeds deal - PP&E disposal proceeds (lab auction ~Phase I–III) - Remaining Genentech collaboration receivables - Any residual USWM milestone accounting You can track it here (Company No. 09338148): https://find-and-update.company-information.service.gov.uk/company/09338148/filing-history
0 · Reply
duepillagence
duepillagence Mar. 15 at 12:14 PM
$ADAPY Know what you hold and stay encouraged fam! A question and answer about iPSCs:
1 · Reply
duepillagence
duepillagence Mar. 15 at 12:01 PM
$ADAPY Question and answer on the impact of TRUc technology in developing allogenic therapies:
0 · Reply
Latest News on ADAPY
No data available.
meatme
meatme Mar. 16 at 8:20 AM
$ADAPY Godoy Almeida said UIHC’s second patient to receive Tecelra therapy started high-dose chemotherapy on March 3, a process that will last for four days, followed by one day of rest and cell infusion the day after rest. https://dailyiowan.com/2026/03/10/rare-cancer-therapy-arrives-at-uihc-iowas-only-medical-center-offering-it/
0 · Reply
Swamp_Yankee
Swamp_Yankee Mar. 15 at 11:02 PM
$ADAPY Piper stole his mother's plastic surgeon's ticket!
0 · Reply
Damage111
Damage111 Mar. 15 at 10:16 PM
$ADAPY I wonder what tomorrow will bring
1 · Reply
BK217
BK217 Mar. 15 at 3:40 PM
$ADAPY HOLD THE LINE!!!
0 · Reply
BK217
BK217 Mar. 15 at 3:38 PM
$ADAPY “think” is doing a lot of heavy lifting here
0 · Reply
duepillagence
duepillagence Mar. 15 at 2:04 PM
$ADAPY $1.50-$2.15 😎
1 · Reply
duepillagence
duepillagence Mar. 15 at 1:06 PM
$ADAPY Question and answer; Can TRUc and iPSCs tech be combined for superior enhancement?:
0 · Reply
meatme
meatme Mar. 15 at 12:47 PM
$ADAPY Key filing to watch: UK Statutory Annual Accounts FY2025 Source: Claude.ai As a UK-incorporated PLC, Adaptimmune remains legally required to file statutory accounts under the Companies Act 2006 — regardless of its SEC deregistration. Deadline: June 30, 2026 (6 months after FY end) This filing will reveal: - Final cash position post US WorldMeds deal - PP&E disposal proceeds (lab auction ~Phase I–III) - Remaining Genentech collaboration receivables - Any residual USWM milestone accounting You can track it here (Company No. 09338148): https://find-and-update.company-information.service.gov.uk/company/09338148/filing-history
0 · Reply
duepillagence
duepillagence Mar. 15 at 12:14 PM
$ADAPY Know what you hold and stay encouraged fam! A question and answer about iPSCs:
1 · Reply
duepillagence
duepillagence Mar. 15 at 12:01 PM
$ADAPY Question and answer on the impact of TRUc technology in developing allogenic therapies:
0 · Reply
duepillagence
duepillagence Mar. 15 at 11:51 AM
$ADAPY The longer a final corporate action takes the closer the share price MUST reflect the market outlook for the following IP's owned by adapy: -TRUc Technology -iPSCs (induced pluripotent stem cells) (stem cells readily available to derive from adult tissues) Are technologies that can be sold as individual IP's. Both enhance the development of allogenic therapies!
0 · Reply
readbet
readbet Mar. 15 at 1:35 AM
$ADAPY, you've got one swamp yank who seems to have designed his profile and tactics just for one stock. Can't say that I am above that on the flip side for something I believe in. Best of luck to you both, but have fun somewhere else. Not sure what you might say if this goes wild like we all think it will.
0 · Reply
readbet
readbet Mar. 15 at 1:30 AM
$ADAPY the real question on ADAPY is not whether we will see $0.22-0.33 again.. that is as good as written given all that we know. If that were not true the ardent haters of the board would not waste their breath incessantly with an obsession-like venom day in and day out. The real question is how long until two or three strikes. Probably not more than a handful of months. If this were such an obvious gutter it would not be worth all the attention.
1 · Reply
BK217
BK217 Mar. 15 at 12:59 AM
$ADAPY the 7 people who clicked “like” are clinically brain dead. Not to mention the author himself…
1 · Reply
Stockinvestor73
Stockinvestor73 Mar. 14 at 10:36 PM
$ADAPY All i want to say is if this company were to go bankrupt i would want to buy its patents at a bankruptcy uction........... i'd much prefer a buyout and news omlestones
0 · Reply
PaidPiper
PaidPiper Mar. 14 at 8:49 PM
$ADAPY yes it's a RATIO. 1:6!!!
2 · Reply
Fab83
Fab83 Mar. 14 at 8:26 PM
$ADAPY So it break even.
0 · Reply
Swamp_Yankee
Swamp_Yankee Mar. 14 at 8:19 PM
$ADAPY @BK217 It's 3:18 AM in Bangkok rn.
1 · Reply
PaidPiper
PaidPiper Mar. 14 at 8:18 PM
$ADAPY 1 ADR = 6 UK shares
0 · Reply
PaidPiper
PaidPiper Mar. 14 at 8:16 PM
$ADAPY yes but remember there's also 1.59 billion uk shares. 265 mil ADRs.
0 · Reply
Fab83
Fab83 Mar. 14 at 7:49 PM
$ADAPY So if a UK stock is worth .30, does that mean my ADR is worth 1.80?
1 · Reply
PaidPiper
PaidPiper Mar. 14 at 7:41 PM
$ADAPY no. You own 336k ADRs. Each ADR is 6 uk shares. If 1 uk share is .001 then 1 of your ADRs is worth .006. Only really matters when deal is announced as it will most likely be announced in uk shares not ADRs. Plz everyone soak this info in lol
0 · Reply